| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |